Über die Spezifische Blutdrucksenkende Substanz des Menschlichen Prostata- und Samenblasensekretes

  title={{\"U}ber die Spezifische Blutdrucksenkende Substanz des Menschlichen Prostata- und Samenblasensekretes},
  author={U. S. von Euler},
  journal={Klinische Wochenschrift},
  • U. Euler
  • Published 1 August 1935
  • Medicine
  • Klinische Wochenschrift
ZusammenfassungDie spezifische, atropinfeste, blutdrucksenkende und Darm-Uterus-erregende Substanz aus Prostata und Samenblasen des Menschen („Prostaglandin“) wird bezüglich gewisser chemischer und biologischer Eigenschaften charakterisiert und von anderen Depressorsubstanzen abgegrenzt. 

Ein Vergleich Zwischen Cystamin und Körpereigenen Blutdrucksenkenden Substanzen

ZusammenfassungEs wird Cystamin mit körpereigenen blutdrucksenkenden Stoffen bekannter und unbekannter Konstitution verglichen und gefunden, daß Cystamin in seiner Kreislaufwirkung eine große

Euler, Ulf von

The adipokinetic property of hypophyseal peptides and catecholamines: a problem in comparative endocrinology1

The sections in this article are: Quantitative In Vitro Assay Method, Multiplicity of Naturally Occurring Adipokinetic Substances, and Species Differences in the Responsiveness to Adipkinetic Substance.

Medical Flogress Prostag land ins, Throm boxanes and Leu kotrienes in Clinical Medicine

This review focuses on those areas of prostaglandin, thromboxane and leukotriene biochemistry and physiology that interact with the contemporary practice of medicine, and makes important contributions to several subspecialties.

Referat Prostaglandine in der Geburtshilfe

Die klinische Anwendung der Prostaglandine zur Schwangerschaftsunterbrechung und Weheneinleitung h~itte wohl kaum eine so rasche Verbreitung erfahren, wenn nicht zugleich die Fachwelt der sicheren

The role of eicosanoids in paediatrics

More specific pharmacological tools than the nonsteroidal antiinflammatory drugs, such as receptor antagonists, selective synthesis inhibitors, and eicosanoid analogues offer the prospect of enriching the arsenal of pharmacotherapeutic interventions in a variety of diseases.

Possible role of prostaglandins in the regulation of coronary blood flow

  • K. Schrör
  • Medicine
    Basic Research in Cardiology
  • 2005
A model is presented, based on the hypothesis that adenosine from myocardial metabolism and PGI2 from vascular sites are acting in concert to antagonize sympathetic metabolic and vasoconstrictory influences and to maintain an adequate blood supply to the heart.

Prostacyclin and Prostaglandins

Pulmonary hypertension is associated with vasoconstriction, thrombosis, and proliferation, and this supports a strong rationale for prostanoid use as therapy for this disease.

The Prostaglandinsin Clinical Medicine . A Developing Role for the Clinical Chemist 9 I 0 I B CUNICAL CHEMISTRY

Clinical aspects of prostaglandins that are discussed include hypertensive diseases, disorders of the gastrointestinal tract, cancer, inflammation and fever, effects on platelets, the respiratory system and asthma, and reproduction.

The use of prostaglandin E1 for diagnosis and treatment of erectile dysfunction

In a series of 550 men with erectile dysfunction who received a test dose of 20 μg prostaglandin E1, 385 (70%) developed an erection lasting more than 30 min and side effects were minimal.



Depressor substances in extracts of intestine

The main conclusions that Euler and Gaddum reached as to the properties of substance P have been confirmed, and it is readily dialysable, and soluble in absolute alcohol, but is rapidly destroyed by strong acid or alkali.

Isolation of a Crystalline Depressor Substance from the Brain

It has been shown 1 , 2 , 3 that a depressor substance is present in certain extracts from brain tissue. Major and Weber 2 presented evidence that the active depressor substance was not histamine

Zur Kenntnis der pharmakologischen Wirkungen von Nativsekreten und Extrakten männlicher accessorischer Geschlechtsdrüsen

  • U. V. Euler
  • Chemistry
    Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie
  • 2005